Prostate Cancer Progression and Therapeutic Resistance: Role of Prostate-Derived Ets (PDEF)

Hari Koul, MSc, PhD
Professor and Interim Head of Biochemistry, and Associate Director of the Stanley S. Scott Cancer Center
Location: Via Zoom

For more information or program materials email Hari Koul, MSc, PhD at hkoul@lsuhsc.edu

Learning Objectives – To understand:

  1. the biology of prostate cancer;
  2. the basis of hormone therapy for prostate cancer;
  3. mechanisms of therapeutic resistance;
  4. expression and role of prostate-derived Ets factor (PDEF); and
  5. purpose of combination therapy


Accreditation: The Louisiana State University School of Medicine, New Orleans is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement: The Louisiana State University School of Medicine, New Orleans designates this live activity for a maximum 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.